Skip to main content

Table 1 Clinico-pathological parameters of 108 SD-BLCA samples analysed in this study by immunohistochemistry

From: Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

  Categorisation na analysable %
Parameter:
 Age at diagnosis: median: 67.5 years   
(range 33–88)   
< 67.5 years 53 49.1
≥67.5 years 53 49.1
na 2 1.8
 Gender male 52 48.1
female 53 49.1
na 3 2.8
 Tumour subtype UC/SCC 45 41.7
SCC 63 58.3
 Histological tumor gradeb G1 1 0.9
G2 29 26.9
G3 73 67.6
G4 1 0.9
na 4 3.7
 Tumour stagec pTx 6 5.6
pT1 1 0.9
pT2 13 12.1
pT3 70 64.8
pT4 18 16.6
 Lymph node status negative (pN0) 66 61.0
positive (pN1 + pN2) 21 19.5
na 21 19.5
  1. aOnly patients with primary bladder cancer were included; bAccording to WHO 1973 classification; cAccording to UICC TNM classification 8th edition; na: not available